Jeisys Medical Inc.
KOSDAQTotal Valuation
Jeisys Medical Inc. carries a market capitalization of 974.74B, placing it among publicly traded companies globally. Its enterprise value stands at 982.85B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 974.74B |
| Enterprise Value | 982.85B |
Share Statistics
Jeisys Medical Inc. currently has 75.43M shares outstanding.
| Shares Outstanding | 75.43M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Jeisys Medical Inc. trades at a trailing price-to-earnings ratio of 35.09.
| PE Ratio | 35.09 |
| PS Ratio | 5.85 |
| PB Ratio | N/A |
| P/TBV Ratio | 8.69 |
| P/FCF Ratio | 26.18 |
| P/OCF Ratio | 40.33 |
Enterprise Valuation
On an enterprise value basis, Jeisys Medical Inc. trades at an EV/EBITDA multiple of 16.54 and an EV/FCF ratio of 25.82. The EV/Sales ratio of 5.86 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 16.54 provides insight into valuation relative to core operating earnings.
| EV / Sales | 5.86 |
| EV / EBITDA | 16.54 |
| EV / EBIT | 16.54 |
| EV / FCF | 25.82 |
Financial Position
Jeisys Medical Inc. maintains a current ratio of 2.00, meaning it holds 2.0x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 2.00 |
| Quick Ratio | N/A |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | 508.69 |
Financial Efficiency
Jeisys Medical Inc. posts a return on equity of 102.61 and a return on invested capital of 38.91.
| Return on Equity (ROE) | 102.61 |
| Return on Assets (ROA) | 16.53 |
| Return on Invested Capital (ROIC) | 38.91 |
| Return on Capital Employed (ROCE) | 76.41 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 4.71 |
Taxes
Over the trailing twelve months, Jeisys Medical Inc. has paid 9.85B in income taxes, reflecting an effective tax rate of 25.72.
| Income Tax | 9.85B |
| Effective Tax Rate | 25.72 |
Stock Price Statistics
Jeisys Medical Inc.'s stock has gained approximately 10.35073% over the past 52 weeks. The 50-day moving average sits at 12,883.80, while the 200-day moving average is 11,030.85.
| Beta (5Y) | N/A |
| 52-Week Price Change | 10.35073% |
| 50-Day Moving Average | 12,883.80 |
| 200-Day Moving Average | 11,030.85 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Jeisys Medical Inc. generated 167.82B in revenue and converted that into 27.97B in net income, yielding earnings per share of 368.26. EBITDA reached 59.42B, while operating income came in at 59.42B.
| Revenue | 167.82B |
| Gross Profit | 117.11B |
| Operating Income | 59.42B |
| Pretax Income | 38.29B |
| Net Income | 27.97B |
| EBITDA | 59.42B |
| EBIT | 59.42B |
| Earnings Per Share (EPS) | 368.26 |
Balance Sheet
| Cash & Cash Equivalents | N/A |
| Total Debt | N/A |
| Net Debt | N/A |
| Equity (Book Value) | N/A |
| Book Value Per Share | N/A |
| Working Capital | 64.25B |
Cash Flow
Jeisys Medical Inc. produced 24.34B in operating cash flow over the past twelve months. After subtracting -13.64B in capital expenditures, free cash flow totaled 10.70B - equivalent to 140.31 per share.
| Operating Cash Flow | 24.34B |
| Capital Expenditures | -13.64B |
| Free Cash Flow | 10.70B |
| FCF Per Share | 140.31 |
Margins
Jeisys Medical Inc. operates with a gross margin of 69.78, reflecting its pricing power and cost economics. The operating margin of 35.41 and net profit margin of 16.67 provide insight into operational efficiency.
| Gross Margin | 69.78 |
| Operating Margin | 35.41 |
| Pretax Margin | 22.82 |
| Profit Margin | 16.67 |
| EBITDA Margin | 35.41 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -3.59 |
| FCF Yield | 3.82 |
Scores
Jeisys Medical Inc. posts an Altman Z-Score of 8.56, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 8.56 |